

CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 50 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 25–50 MCG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
Levotiron provides levothyroxine sodium (T4), the first-line therapy for documented hypothyroidism. In athletes and high-output trainees, restoring a euthyroid state supports normal metabolism, recovery capacity, and training consistency—without resorting to unsafe shortcuts. This is a prescription medication with an FDA boxed warning: thyroid hormones must not be used for weight loss in euthyroid individuals. Use only as directed by a licensed clinician.
T4 is a prohormone that peripheral tissues convert to T3, the bioactive thyroid hormone. When your own production is insufficient, everything from resting metabolic rate to protein turnover and mitochondrial function can suffer. Correct replacement helps normalize energy, mood, thermoregulation, and exercise tolerance—key pillars for productive training blocks. T4's long half-life (~1 week) makes once-daily scheduling practical and keeps blood levels steady between sessions, competitions, and travel days.
After oral dosing, levothyroxine is absorbed in the small intestine (jejunum/ileum). In target tissues, deiodinase enzymes convert T4 → T3 as required. This tissue-specific conversion is a feature, not a flaw: it lets muscle, liver, and the nervous system "pull" the active hormone they need, while T4 provides a stable reservoir. For most patients with primary hypothyroidism, T4 alone is sufficient. If symptoms persist despite appropriate dosing and labs, your clinician will consider causes (absorption interference, adherence, GI issues, drug interactions, or in select cases, trialing combination therapy).
Form & strength: each tablet contains 50 mcg levothyroxine sodium. Many adults begin at 25–50 mcg once daily, adjusting every 4–6 weeks until the lowest effective maintenance dose is reached. Older adults or those with coronary disease/arrhythmia risk often start at 12.5–25 mcg with slower titration. In central (secondary/tertiary) hypothyroidism, TSH can be unreliable; clinicians rely on FT4 (and sometimes T3) plus symptoms and vitals.
Authoritative labeling: for indications, boxed warning, and dosing principles, see the FDA prescribing information (example: Levothyroxine Sodium Tablets FDA label).
T4 is not a "fat burner." In euthyroid people, excess thyroid hormone risks muscle loss, insomnia, and bone effects while offering little sustainable benefit. For athletes with diagnosed hypothyroidism, however, appropriate T4 replacement supports:
Medication changes (estrogens, enzyme inducers), malabsorption syndromes (celiac disease, IBD), and adherence/meal timing will shift dose requirements. Anticoagulants and antidiabetics may need adjustment after thyroid dose changes; always tell your clinician about new prescriptions or supplements. If persistent symptoms remain despite TSH/FT4 normalization, consider absorption review (timing, binders), sleep/CPAP, iron deficiency, or overreaching in training.
Think of T4 as restoring a baseline. Your performance still depends on periodized training, adequate protein (1.6–2.2 g/kg/day for most athletes), sufficient calories in massing blocks, and energy availability in cuts. Stress management and sleep (7–9 hours) keep thyroid and HPA axes cooperative. If your plan introduces aromatizable androgens, coordinate with your clinician—thyroid dose is usually kept stable while estrogen control and lipid management are addressed separately.
Tissue repair & recovery: In consultation with your clinician, some athletes explore peptides alongside structured rehab when dealing with soft-tissue strain:
Sleep/GH axis support: For athletes working on sleep quality and recovery architecture:
Cutting-phase context: If your coach has you trialing a mild oral in advanced phases, ensure thyroid dosing stays stable and labs guide any endocrine decisions:
Under-replacement: fatigue, cold intolerance, constipation, dry skin/hair, menstrual changes, bradycardia, depressed mood.
Over-replacement: palpitations, tachycardia, tremor, heat intolerance, anxiety, insomnia, diarrhea, weight loss. Chronic excess may reduce bone mineral density. If these occur, or if you begin new medications affecting absorption/metabolism, contact your prescriber for labs and dose review.
This listing is for Abdi İbrahim Levotiron 50 mcg tablets (50 count). Store at room temperature away from moisture, heat, and light. Keep out of reach of children. We ship discreetly in the USA with secure checkout.
Medical disclaimer: Information provided for educational purposes; not a substitute for individual medical advice. Use only under licensed medical supervision and in accordance with local laws.
No. Thyroid hormones carry an FDA boxed warning and must not be used for obesity or weight loss in euthyroid patients. Levotiron is for diagnosed thyroid conditions under medical supervision.
Many adults start at 25–50 mcg once daily; older adults/cardiac patients often begin at 12.5–25 mcg. Clinicians adjust every 4–6 weeks based on symptoms and labs to reach the lowest effective dose.
Take on an empty stomach with water at the same time daily—30–60 minutes before breakfast or at bedtime (3–4 hours after the last meal). Separate from iron, calcium, antacids, and high-fiber/soy foods by several hours.
Under-replacement: fatigue, cold intolerance, constipation, dry skin/hair. Over-replacement: palpitations, tremor, heat intolerance, anxiety, insomnia, weight loss. Report symptoms so your clinician can adjust your dose.
Most patients do well on T4 alone. In select cases with persistent symptoms, clinicians may consider adjunct T3 after ruling out absorption issues and interactions. This is individualized and lab-guided.
Please log in to write LEVOTIRON 50 MCG review.
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 125 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 175 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 150 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 75 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 200 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 100 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 12.5-25 MCG/DAY
ACNE: NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE (T4)
ACTIVE SUBSTANCE: LEVOTHYROXINE SODIUM
FORM: 50 TABLETS x 25 MCG
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: MEN 25–50 MCG ONCE DAILY
ACNE: NOT TYPICAL
WATER RETENTION: ONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: ABDI IBRAHIM
CLASSIFICATION: THYROID HORMONE
ACTIVE SUBSTANCE: LIOTHYRONINE SODIUM
FORM: 100 TABLETS x 25 MCG
ACTIVE HALF-LIFE: 1 DAY
DOSAGE: MEN 25-75 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): YES
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS